Financial Daily from THE HINDU group of publications
Wednesday, Jul 02, 2003
News
Features
Stocks
Port Info
Archives

Group Sites

 Corporate - Announcements


Neuland exports ciprofloxacin to US

Our Bureau

HYDERABAD, July 1

NEULAND Laboratories Ltd (NLL), the Hyderabad-based pharmaceutical company, has informed the stock exchanges on Tuesday that it has executed the first commercial shipment of Ciprofloxacin Hydrochloride USP valued at $40,80,00 to the US

Article E-Mail :: Comment :: Syndication

Stories in this Section
Corolla, Qualis to cost more

Neuland exports ciprofloxacin to US
Oberoi snaps tie-up with Jass Hotel
Reliance hikes product prices
BEL bags TN police order for networking
Zodiac Clothing to pay 50 pc
Bharatiya Intl to pay Rs 2/ share
EKL gets Rs 45-cr grant from AB Electrolux
OSIC plans bond issue for high-cost debt swap
Foreign banks stay away from CDR mechanism — IBA taking efforts to pull them on board
VSNL acquires international IP-VPN service provider
Zenovus to be merged with Dr Reddy's
Global division in place for commercial vehicles — Tata Engg eyes newer foreign markets
Century Plywoods to enter laminate market soon
Indal to expand Hirakud smelter
GAIL inks pact with PY-1 Consortium — For sale, transportation of gas
`We would like to double volumes in the next 3-4 years' — Mr Praveen P. Kadle, ED (Finance & Corporate Affairs), Tata Engg
`CFOs to be custodians of co's intangible wealth'
Hindustan Fluorocarbons officials pulled up by BIFR
Sujana Metal gets ad hoc debt revamp package
HC orders winding up of Ahura Welding
Takeover of National Standard Duncan units — BIFR directs Tata SSL to submit a tied-up proposal
Bajaj Auto 2-wheeler sales dip 7.5 pc in Q1
Hero Honda sales up 15 pc in June

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line